Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Ugay (Vladivostok, Russian Federation), E. Kochetkova (Vladivostok, Russian Federation), V. Nevzorova (Vladivostok, Russian Federation), T. Hairzamanova (Vladivostok, Russian Federation). Topical evaluation of growth factors in arterial remodeling in patients with COPD and osteoporosis. 2984

Member's Comments

No comment yet.

Related content which might interest you: Smoking induced pulmonary vascular remodelling in patients with mild COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation Source: Eur Respir J 2014; 43: 1306-1315 Year: 2014 Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension Source: Eur Respir J 2009; 34: 662 Year: 2009 Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017 Year: 2018 Is COPD a risk factor for increased arterial stiffness? Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD Year: 2008 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Blunted muscle angiogenic training-response in COPD patients versus sedentary controls Source: Eur Respir J 2013; 41: 806-814 Year: 2013 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 The role of the constitution factors and some blood antigens in the development of osteoporosis in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 324s Year: 2006 Chronic thromboembolic pulmonary hypertension: role of medical therapy Source: Eur Respir J 2013; 41: 985-990 Year: 2013 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension Source: International Congress 2015 – COPD: interesting notes Year: 2015 The role of combination therapy in managing pulmonary arterial hypertension Source: Eur Respir Rev 2014; 23: 469-475 Year: 2014 Combined therapy of severe osteoporosis for patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001